Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Mar 14
Love0

Update on Hormonal Therapy in Hidradenitis Suppurativa

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory disease of the apocrine gland-bearing areas such as the axilla, groin, and perianal skin, which is characterized by deep seated painful nodules,…
Read More
Mar 14
Love0

Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports

By Chuck Lin No Comments
INTRODUCTIONSemaglutide is a glucagon-like peptide-1 (GLP-1) analog that was FDA-approved in 2017 for treatment of type II diabetes and in 2021 for treatment for chronic weight management in adults with…
Read More
Mar 14
Love0

Open-Label Phase 2 Pilot Study of Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE)

By Chuck Lin No Comments
INTRODUCTIONDiscoid lupus erythematosus (DLE) is a chronic inflammatory skin disease that occurs with or without systemic lupus erythematosus (SLE). DLE treatment is challenging, and there is paucity of effective therapeutic…
Read More
Mar 07
Love0

Dupilumab Induced Hair Regrowth in Alopecia Totalis

By Chuck Lin No Comments
INTRODUCTIONAlopecia areata (AA) is a form of non-scarring alopecia that results from an autoimmune process that targets hair follicles.1 The severity of the disease varies from a focal, patchy hair…
Read More
Mar 07
Love0

Pityriasis Alba in Pediatric Patients With Skin of Color

By Chuck Lin No Comments
COMMENTARYThe most recently suggested curricular guidelines presented by the Pediatric Dermatology Research Alliance Special Interest Group in Pediatric Skin of Color (PSOCG) listed pityriasis alba (PA) as the second most…
Read More
Mar 01
Love0

Efficacy and Safety of 1% Clascoterone Cream in Patients Aged > 12 Years With Acne Vulgaris

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris, the eighth most prevalent disease globally,1,2 is a multifactorial skin condition characterized by the excess production of sebum, epithelial follicle hyperkeratinization, and inflammation.1-3 Clinical manifestations of acne can…
Read More
Mar 01
Love0

A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia

By Chuck Lin No Comments
INTRODUCTIONWhen considering treatment strategies and formulations that can target hyperpigmentation, two major challenges exist. Firstly, the causes, triggers, and pathways involved are multifaceted and plentiful. Not all pigmentary conditions are…
Read More
Feb 23
Love0

Breaking the Frustrating Cycle of Topical Steroids in Psoriasis: A Review of a Novel Vehicle for Fixed-Dose Combination Halobetasol Propionate/Tazarotene

By Chuck Lin No Comments
INTRODUCTIONTopical treatments are often used both as first-line monotherapy for mild plaque psoriasis and as adjunct therapy for patients with more severe disease.1-3 Psoriasis is a chronic condition, and patients…
Read More
Feb 23
Love0

Evaluating Sentiment, Engagement, and Perception of Biologics Among Patients with Psoriasis and Psoriatic Arthritis on Reddit

By Chuck Lin No Comments
INTRODUCTIONSocial media is becoming increasingly popular as a means for dermatology patients to access health information. In one Swiss study, researchers found that 82.4% of dermatology patients had used the…
Read More
Feb 22
Love0

Development and Validation of a Photonumeric Scale for Evaluation of Lip Fullness

By Chuck Lin No Comments
INTRODUCTIONThe lips are one part of an aesthetic unit that includes the teeth, gingiva, and bone structure of the face and contribute significantly to the overall impression of personal beauty.1-3…
Read More
Feb 22
Love0

Trends in Oral Antibiotic Use for Acne Treatment: A Retrospective, Population-Based Study in the United States, 2014 to 2016

By Chuck Lin No Comments
INTRODUCTIONAcne vulgaris is a common skin disease affecting ~9% of the global population and ~85% of the population aged 12 to 24 years.1 Clinical management of acne primarily targets inflammation…
Read More
Feb 21
Love0

Topical Anesthetic Use in Cosmetic Dermatology

By Chuck Lin No Comments
INTRODUCTIONTopical anesthetics are medications that are commonly used in medicine to obtain local anesthesia via topical application. They have a role in providing local anesthesia in cutaneous procedures, ocular procedures,…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • JDD Podcast: Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology April 3, 2026
  • Do the Eyes Have It? Corticosteroid Use and Stewardship in Ophthalmology April 3, 2026
  • Dermatology Roundup: NPF Clarifies Definition of Psoriasis Disease Severity April 2, 2026
  • Delays in Medical Care Among Skin of Color Melanoma Patients: A Population-Based Study April 1, 2026
  • JDD Re:View With Dr. Beer April 1, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram